DHCare

Based in the US, DHCare specializes in manufacturing innovative medical devices that enhance the quality of life for individuals with reduced mobility. DHCare is focused on the development of medical solutions targeting mobility challenges. The company was formed in January 2026 following the merger of Direct Healthcare Group Ltd. and Invacare Corporation, which were acquired by Rhone Group in July 2025.

CEO Graham Ewart leads this newly combined entity. The company operates its headquarters in the United States and has engaged in one funding deal to date on January 30, 2026. DHCare specializes in delivering a comprehensive range of innovative medical devices designed to enhance the quality of life for individuals experiencing reduced mobility. The company's core product offerings include mobility aids, support surfaces, and specialized seating solutions, all engineered to address specific challenges faced by end-users, including those with disabilities, elderly individuals, and patients recovering from surgeries.

These products are designed to promote independence and improve overall well-being, with an emphasis on user-friendly functionality and safety. DHCare's solutions are marketed to healthcare providers, rehabilitation facilities, and direct consumers, particularly in regions such as North America, Europe, and Asia-Pacific. DHCare generates revenue through a multi-faceted transaction structure that includes direct sales to healthcare providers, partnerships with rehabilitation centers, and direct-to-consumer sales channels. These transactions typically involve bulk purchasing by institutions, allowing for streamlined distribution and access to DHCare's extensive portfolio of mobility solutions.

In addition to one-time purchases, the company may engage in subscription models for ongoing product maintenance and support services, thereby ensuring continuous engagement with clients. Flagship products, renowned for their innovation, contribute significantly to the revenue stream, as demand from both institutional and individual customers persists. The structure of these revenue-generating activities underscores the company's commitment to providing essential products that enhance mobility and independence for their users. Looking ahead, DHCare plans to introduce new products aimed at enhancing mobility solutions in the upcoming quarters, with specific release dates yet to be confirmed.

The company is targeting expansion into new markets, particularly in Europe and Asia-Pacific, by the end of 2027. The recent merger and acquisition strategy will enable DHCare to strengthen its market position in the medical sector, enhancing its reach and capabilities.